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Overview
This chapter considers a number of determinants of health that have become recog-
nized as signifi cant to public health practice. Whilst these are certainly not new, their 
relevance to public health research and practice has only relatively recently become 
acknowledged by mainstream practitioners. The determinants selected for inclusion in 
this chapter are considered especially pertinent to contemporary and future public 
health practice in the UK and globally, namely: human rights, armed confl ict and genetics.
Overall learning objectives:
For each of these emerging determinants the reader will learn how the fundamental 
building blocks of public health may be applied in novel areas of knowledge, research 
and practice. By the end of this chapter you will have learned that basic public health 
principles and methods prove just as relevant in understanding these new contexts as 
in more traditional areas.
Further learning objectives are provided for each section in this chapter.
Key terms are also described in each section in this chapter.
HUMAN RIGHTS
Human rights as a tool for public health
Nineteenth-century public health interventions, and the emerging public health acts 
that underpinned those interventions, were predicated on the assumption that the 
public good justifi ed infringement of individual liberties. Measures such as quarantine, 
detention, compulsory medical examination and vaccination were commonly employed 
weapons for disease control in the armoury of most states (see Chapter 1). Such 
powers were wide ranging; there were few obligations to review decisions or rights of 
appeal against them. However, with the emergence of a body of health ethics in the 
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second half of the twentieth century, and the increasing prominence of the doctrine of 
human rights, the assumption that the public good always overrides individual rights 
and liberties came to be questioned. This section will examine how the recognition of 
human rights has infl uenced attitudes to public health interventions, and how public 
health legislation has been amended to refl ect this growing recognition of human 
rights. It will also consider how the recognition of human rights might assist rather than 
constrain the exercise of public health practice.
Human rights are viewed as a tool for the better implementation of public health 
rather than as an obstacle to public health, because:
• human rights ensure that all public health measures are carried out with respect for 
the dignity and worth of communities and their members;
• by this, they encourage public confi dence in, and increase the legitimate authority 
of, health measures;
• human rights recognize that to live in an environment conducive to public health 
is a fundamental right.
However, it might be argued that human rights can act contrary to public health. This 
tension is explored next.
Learning objectives
By the end of this section you will be able to:
• describe the emergence of human rights arguments in public health
• recognize and explain legal frameworks for protection of rights relevant to public 
health
• describe the public health measures that might potentially infringe acknowledged 
rights
• recognize ways in which compliance with human rights might benefi t public 
health
Key terms
Human rights The Universal Declaration of Human Rights states that:
‘All human beings are born free and equal in dignity and rights. They are endowed with 
reason and conscience and should act towards one another in a spirit of brotherhood’ 
(Article 1), and that:
Everyone is entitled to all the rights and freedoms set forth in this Declaration, 
without distinction of any kind, such as race, colour, sex, language, religion, political 
or other opinion, national or social origin, property, birth or other status. 
Furthermore, no distinction shall be made on the basis of the political, jurisdictional 
or international status of the country or territory to which a person belongs, 
whether it be independent, trust, non-self-governing or under any other limitation 
of sovereignty (Article 2).
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The interrelationship of human rights and public health
The Universal Declaration of Human Rights, cited above, provides a basis for protec-
tion of human rights everywhere, although in a far from perfect world there are too 
many examples of states that violate these rights. The principles set out in the 
Declaration have been transposed into many national and international laws. In a single 
chapter it is not possible to look at the many nationally specifi c provisions; instead we 
illustrate the key issues by reference to one international legal instrument, the European 
Convention on Human Rights. First, however, we examine the evolution of public 
health law and how it has been informed by human rights issues in one typical country, 
England.
England’s fi rst national Public Health Act in 1848 provided a model for public health 
legislation around the world, not just in Britain and its colonies but in other countries, 
such as Japan. The Act provided powers to intervene in relation to both places (water 
supplies, sewerage, housing, rubbish, etc.) and people. In relation to people, the Act 
provided a range of compulsory powers including compulsory medical examination 
and compulsory detention in a hospital for an unlimited time, with no review or appeal 
procedures. Reforms were introduced in the 1936 version of the Public Health Act, 
providing protections for civil liberties, for example by establishing limits on the time 
people could be detained and the rights to seek a review of a detention order, but 
these protections were abandoned in 1968 when a range of public health measures 
were consolidated into a single Act. They were not reinstated in the Public Health Act 
of 1984.
The development of public health legislation took place against a background of legal 
provisions recognizing the rights of individuals against interventions by the state. The 
Universal Declaration of Human Rights was adopted and proclaimed in 1948, and the 
European Convention on Human Rights came into force in 1953. While several of 
the rights listed in these documents had relevance for public health interventions, it 
was some time before states and public health communities recognized that commonly 
accepted public health measures might be constrained by the provisions of these 
human rights instruments.
The revised International Health Regulations (IHR 2005), produced by WHO, have 
enshrined the importance of human rights in the exercise of public health. The require-
ment that WHO members states comply with the IHR has prompted countries 
around the world to revise their public health legislation.
In England and Wales, the Health and Social Care Act 2008, Part 3, amending the 
1984 Public Health Act, introduces some human rights constraints on public health 
measures, particularly procedural protections against abuse of quarantine and isolation 
powers. For example, a public health measure imposed on an individual must now be 
proportionate to what it seeks to achieve (section 45D), compulsory medical treat-
ment and vaccination are prohibited (section 45E), and there are provisions for review 
and appeals against compulsory power orders (section 45F).
The European Convention on Human Rights (ECHR) and how it might constrain 
public health measures
The ECHR lists rights that signatories, including all EU member states, must comply 
with the exercise of governmental powers. Some of the rights in the ECHR are ‘quali-
fi ed’, which means that restrictive measures can be justifi ed in certain circumstances. 
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Examples are Article 8 (right to respect for private and family life), Article 9 (freedom 
of thought, conscience and religion), Article 10 (right to freedom of expression) and 
Article 11 (freedom of assembly and association). Article 5 (the right to liberty and 
security) is a ‘limited’ right and restrictions can only be imposed in certain specifi ed 
circumstances. The ECHR also sets out ‘absolute’ rights that cannot be interfered with 
under any circumstances, such as Article 3 (prohibition on torture, inhuman or degrad-
ing treatment), Article 4(1) (prohibition on slavery) and, arguably, Article 6 (right to a 
fair trial).
Compulsory vaccination, treatment or medical examination
Interventions such as compulsory vaccination, examination and treatment raise issues 
in relation to Article 3 (inhuman and degrading treatment), Article 8 (the right to 
private and family life) and Article 9 (freedom of thought, conscience and religion) of 
the ECHR.
If Article 3, an absolute right allowing for no exceptions, is to be invoked, it must fi rst 
be determined whether the medial intervention in question amounts to inhuman and 
degrading treatment. Ill treatment must be of at least a minimum level of severity to fall 
within the scope of the Article and factors taken into account include the duration of 
the treatment, its physical or mental effects and the sex, age and state of health of the 
victim (Abdulaziz 2005). The European Court has in the past stated that there must be 
an element of humiliation to count as ill treatment (Labita 1995), going beyond the 
‘inevitable element of suffering or humiliation connected with a given form of legiti-
mate treatment or punishment’. In the case of Jalloh v. Germany (Jalloh 2000) for exam-
ple, the administration of emetics (to cause vomiting) against a patient’s will was held 
to be a violation of Article 3.
The courts are generally quicker to rule that inhuman or degrading treatment 
has taken place where a citizen is detained by the state. ‘Where a person is deprived 
of his liberty, the State must ensure that he is detained under conditions which are 
compatible with respect for his human dignity and that the manner and method of 
the execution of the measure do not subject him to distress or hardship exceeding 
the unavoidable level of suffering inherent in detention (A and others 2005). Concerns 
might arise where a citizen is detained under a compulsory quarantine power and, 
on the word of a single doctor, subjected to an invasive medical examination. Where 
a patient refuses to consent to invasive medical examination or treatment, there is 
often an underlying religious or cultural reason for doing so. In these circumstances 
forced medical examination could be seen as disrespectful and humiliating to the 
individual.
Where the intervention does not amount to inhuman and degrading treatment, 
Articles 8 or 9 could come into play and, as these are both qualifi ed rights, the pro-
posed infringement would be subject to the balances set out in the Convention. These 
balances consider whether the measure is in accordance with the law, in pursuit of a 
legitimate aim and necessary and proportionate in a democratic society. The doctrine 
of patient consent is a core value in medical law and the European Court is reluctant 
to interfere with a competent patient’s decision to refuse treatment, even where such 
refusal might harm the patient (re AK 2001). However, the harm being considered in 
the context of disease control is harm not only to the patient him/herself, but also 
harm to the wider public.
There have been surprisingly few challenges to the use of compulsory powers in 
this way, perhaps because the diseases where such powers are most commonly 
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exercised, for example in relation to tuberculosis, often arise in migrant, poor and 
insular communities who might have limited access to legal knowledge or assistance.
Quarantine and detention
These measures may potentially infringe Article 5: ‘Everyone has the right to liberty and 
security of person. No one shall be deprived of his liberty save in the following cases 
and in accordance with a procedure prescribed by law.’
As Article 5 is a limited right, restrictions on liberty and security will only be lawful 
if they are for a purpose listed in the ECHR. One such purpose does relate specifi cally 
to public health: (e) the lawful detention of persons for the prevention of the spreading of 
infectious diseases.
In the case of Enhorn v Sweden (Enhorn 2000), an HIV positive man who had trans-
mitted the virus to another was held in isolation by the Swedish public health authori-
ties. He challenged his detention in the European Court of Human Rights, arguing that 
his ECHR rights had been breached (Martin 2006). The Court held that in order for a 
detention to be lawful:
• the measure must be proportionate;
• there must be an absence of arbitrariness;
• the detention must be a last resort measure;
• the detained person must be suffering from an infectious disease;
• the spread of disease must be dangerous to public safety and;
• the detention must have as its objective not only protection of the healthy but also 
care of the ill.
The Court found that the Swedish Government had failed to consider whether 
any lesser measures could have achieved the same outcome of protecting public health 
and thus the measure was not a last resort. Accordingly, there had been a breach of 
Article 5.
The legality of the quarantine or isolation, and in particular large-scale programmes 
envisaged in many national pandemic preparedness plans, would need to be judged 
under the conditions set out in the Enhorn judgement. It is important to note that HIV 
is not transmitted in the same way as infl uenza, which is spread considerably more 
easily and is usually airborne (Health and Safety 2009). The European Court, therefore, 
might be inclined to allow detention on health grounds more readily than in the Enhorn 
case. The counter argument is that the speed of transmission makes isolation almost 
redundant, as transmission may well have occurred before an infected person enters 
quarantine or detention.
It is likely that quarantine will be more diffi cult to justify than simple isolation. 
Although both measures potentially infringe human rights, there is a stronger 
public health argument for containing those infected in isolation. Article 12(1) of the 
International Covenant on Economic, Social and Cultural Rights recognizes ‘the right of 
everyone to the enjoyment of the highest attainable standard of physical and mental 
health’. Isolation of people displaying symptoms is arguably necessary both for the 
health of the public at large and in the interests of society in controlling the spread of 
the virus (Boggio et al. 2008). Quarantine, however, envisages the detention of those 
not yet displaying symptoms, on the basis that some of those detained are at risk of 
developing the disease and thus may pose a risk to others. This can mean detaining 
those who might develop symptoms together with those who might not, putting the 
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health of some persons at risk for the benefi t of others. Concerns were raised by the 
Nuffi eld Council on Bioethics (2007) that quarantine might be implemented inappro-
priately or abused. At issue also is whether the measure is actually effective. In the 
SARS outbreak some 1200 people were quarantined in Hong Kong and 131,000 in 
Taiwan (Gostin and Berkman 2007). Quarantine was later considered of limited effect 
due to the diffi culty in diagnosing mild cases, the raised level of panic that the measure 
created, and the number of violations of it (Rothstein et al. 2003).
Fear of quarantine can make people reluctant to seek diagnosis and can result in 
stigmatization of groups or individuals (Murphy and Whitty 2009). If quarantine is not 
considered effective, any benefi t in terms of protecting the public will be reduced and 
it will be harder to demonstrate proportionality. The WHO guidelines on prepared-
ness planning state that the use of social distancing measures such as isolation and 
quarantine ‘must be carefully circumscribed and limited to circumstances where they 
are reasonably expected to provide an important public health benefi t’ (World Health 
Organization 2007) and that isolation should be voluntary to the greatest extent 
possible.
Relevant factors would include whether the period of quarantine or isolation is time 
limited and whether the detention is subject to regular review. Other considerations, 
related to proportionality and arbitrariness, include the degree of due process (such as 
whether the detained person is allowed a right of appeal) and whether plans are in 
place to detain separately those displaying symptoms from those who might only 
potentially be infected (Gostin and Berkman 2007).
Rights of review and appeal
Article 6 of the ECHR provides that, ‘In the determination of his civil rights and obliga-
tions or of any criminal charge against him, everyone is entitled to a fair and public 
hearing within a reasonable time by an independent and impartial tribunal established 
by law.’
This is arguably an absolute right (Brown v Stott 2001), entitling citizens to a fair trial 
including the right to take court proceedings to settle a civil dispute. The courts have 
held that the right includes access to a court; adequate notice of a hearing and time to 
prepare a defence; and a proper opportunity to present one’s case (Dombo Beheer 
1993). There is also an obligation on the state to provide legal assistance for persons 
that have been isolated or put in quarantine, as they are not able to arrange adequate 
defence for themselves (Megyeri v Germany 1992). Many states in Europe and else-
where, including until recently England and Wales, do not provide procedures for 
review or appeal of compulsory orders such as for quarantine or detention (Martin 
et al. 2010).
Medical information sharing
Systems of surveillance to track the spread of infections and isolate those infected are 
vital in containing disease (Gostin and Berkman 2007). However, such systems have 
implications for the right to privacy under Article 8 of the ECHR. As with medical 
interventions, an important consideration will be whether control could be achieved 
by lesser means. The Home Affairs Select Committee in the United Kingdom Parliament 
considered the issue of data collection in 2008 (Home Affairs Committee 2008) and 
suggested a move towards ‘data minimalization’ – collecting only necessary data and 
storing it for the shortest amount of time possible.
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Human rights and non-communicable diseases
Issues of human rights are less likely to arise in the context of public health measures 
to prevent or control non-communicable diseases. Despite arguments by the pro-
tobacco or pro-alcohol lobbies, there is no legally recognized right to smoke or to 
drink alcohol. What is at issue here are not rights but freedoms – individuals arguing that 
their freedom or autonomy is being constrained by tobacco or alcohol restrictions and 
taxes, or on controls on fast food advertising. The counter argument is that our free-
dom or autonomy to choose has been deliberately eroded by intensive advertising, and 
by the availability and use of addictive substances, such that public health interventions, 
for example, prohibition on advertising or protection of smoke-free public places, are 
necessary to restore our freedom to choose a healthy lifestyle rather than eroding it.
One issue that has raised human rights arguments is the fl uoridation of water supplies. 
This is complex because someone living in an area where there is fl uoridation does not 
have a realistic freedom to choose not to drink fl uoridated water. In many countries, argu-
ments based on public benefi t and utilitarianism (the greatest benefi t for the greatest 
number) have prevailed. There have also been claims that fl uoridation is harmful to health 
(it is, but only at levels far higher than those in fl uoridated drinking water), but if such argu-
ments were true then human rights might become an issue in the context of fl uoridation.
The 2005 International Health Regulations (IHR) and human rights
The revised IHR 2005 explicitly requires that human rights be taken into account in 
the exercise of public health measures, stating that ‘the implementation of the IHR shall 
be with full respect for the dignity, human rights and fundamental freedoms of all per-
sons.’ The IHR make clear that states must recognize principles of human rights in that
• state responses must be appropriate;
• any measures taken must be no more intrusive than available alternatives;
• consent should be obtained for measures unless compulsory measures are 
warranted;
• there is an obligation to preserve the confi dentiality of identifi able information.
These provisions place a responsibility on nations to ensure both that their public 
health laws incorporate human rights principles, and that public health practice is exer-
cised in accordance with these principles.
Human rights recognition can benefi t public health
The protection by the state of rights and freedoms is fundamental for public trust in 
government initiatives, and if the public is to cooperate with public health measures. 
Enforcement of measures is not always easy or practical. A population-wide refusal to 
comply with anti-smoking legislation or with prohibitions on public gatherings to con-
trol spread of disease, could severely damage public health objectives (although it is 
important to ascertain the true level of support, as one may argue that the tobacco 
industry, for instance, has under-played the widespread support for bans on smoking in 
public places – see Chapter 8 for more on this topic). This is especially so in circum-
stances of a disease pandemic. Indeed pandemic preparedness plans rely heavily on 
volunteers, on home nursing, on neighbours taking food to the sick and on care for the 
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children of the sick. We can see this from the pandemic simulation exercises that have 
taken place for assessing the feasibility of plans.
The success or failure of disease control measures lies not with enforcement mech-
anisms but with the willingness of the population to behave responsibly and in accord-
ance with communitarian values. Where the state fails to recognize either limits on its 
powers or the need not to sacrifi ce the rights of individuals for the public benefi t, then 
trust and cooperation are less likely. The objective of public health practice is care and 
protection of the population against all threats to health. It is not law enforcement for 
the sake of it. Countries with the most draconian public health powers are rarely those 
with the highest level of public trust or the best population health. The recognition by 
the state of individual rights is a good starting point to creating the public trust neces-
sary to achieve effective public health.
Of course the achievement of public support for public health initiatives is not just 
about rights. It is also about justice in the distribution of public health burdens, and about 
social justice in access to opportunities and goods. It concerns normative responsibilities 
to redress inequalities, to care for those most at risk of public health harms, and to redis-
tribute goods so that all members of the population have an equal opportunity to survive 
a threat to public health. While rights documents often focus on what states must not do, 
rather than on responsibilities of states to take positive action for the protection of their 
populations, some human rights instruments have attempted to impose positive obliga-
tions on states to assist in the achievement of conditions for health. The Universal 
Declaration of Human Rights, for example, states the following in Article 25:
• Everyone has the right to a standard of living adequate for the health and well-being 
of himself and of his family, including food, clothing, housing and medical care and 
necessary social services, and the right to security in the event of unemployment, 
sickness, disability, widowhood, old age or other lack of livelihood in circumstances 
beyond his control.
• Motherhood and childhood are entitled to special care and assistance. All children, 
whether born in or out of wedlock, shall enjoy the same social protection.
And Article 12(1) of the International Covenant on Economic, Social and Cultural 
Rights recognizes ‘the right of everyone to the enjoyment of the highest attainable 
standard of physical and mental health’.
One thing that can be achieved by an enforceable legal framework of human rights is 
to make clear that everyone has a right to the minimum conditions necessary to attain 
health, and that the state has an obligation to work towards the attainment of these 
conditions. This supports an expectation by the population of a healthy environment, 
and supports the work of individuals and lobby groups working to improve public health.
Activity 9.1
The following Open Access paper can be found at: http://medicine.plosjournals.org/
perlserv/?request=get-document&doi=10.1371/journal.pmed.0040050
Singh JA, Upshur R and Padayatchi N (2007) XDR-TB in South Africa: no time for 
denial or complacency. PLoS Med 4(1): e50.
Commenting on this paper, Coker et al. wrote (Coker R, Thomas M, Lock K and Martin 
R (2007) Detention and the evolving threat of tuberculosis: evidence, ethics and law. J 
Law Med Ethics 35(4): 609–15, 512.
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Singh et al.’s paper on the challenge posed by XDR-TB in South Africa stimulated 
afresh the debate around the use of detention in order to protect public health. The 
debate originated a decade earlier when New York City, responding to its epidemic 
of drug resistant tuberculosis in the early 1990s, passed laws facilitating the deten-
tion of non-infectious individuals and shifting the burden of proof from an assess-
ment of risk posed to public health to an assessment of likely treatment compliance. 
In relation to XDR-TB in South Africa, the authors propose that under some cir-
cumstances individuals might be isolated whilst awaiting susceptibility results. They 
advocate initial voluntary isolation of patients with drug resistant tuberculosis, sep-
arating those with multi-drug resistance from those with extensive drug resistance, 
and recommend coercive measures where voluntary isolation is declined, acknowl-
edging that the duration of isolation may potentially be indefi nite or until death in 
some cases of XDR-TB. The authors conclude: ‘Although such an approach might 
interfere with the patient’s right to autonomy and will undoubtedly have human 
rights implications, such measures are reasonable and justifi able, and must be seen 
in a utilitarian perspective. Ultimately in such cases, the interests of public health 
must prevail over the rights of the individual.’
After reading the paper by Singh et al. consider the following questions in the context 
of Europe, where the European Convention on Human Rights applies:
1  What human rights issues arise in relation to involuntary detention of persons who 
have not yet been confi rmed as having MDRTB or XDRTB?
2  Where an individual has been confi rmed as suffering from multi-drug resistant tuber-
culosis, what human rights concerns might arise where a decision is made to detain 
that person on grounds that his/her personal or social circumstances suggest that 
he/she might not comply with a treatment regime?
3  Would it infringe a person’s human rights to detain that person without specifying 
the length of the detention?
4  Could compulsory treatment of a person with MDR/XDR tuberculosis be justifi ed 
on public health grounds?
5  Is it the case that, as Singh et al. suggest, ‘Ultimately in such cases, the interests of 
public health must prevail over the rights of the individual’?
6  Should we take in to account, in considering the questions above, the differing 
disease context in Africa? Would it be justifi able to accept differing levels of human 
rights protection in different countries?
Feedback
1  There is a prima facie breach of the detained person’s right to liberty and security, 
and right to family life, by them being detained. Detention is only justifi ed if it is 
imposed for the purpose of protection of public health, if it is the least restrictive 
alternative measure, if the choice of whom to detain is not discriminatory, if the risk 
posed by the detained person outweighs the harm done by the detention, and if the 
place of detention is appropriate to the health of the detained person.
  There is also a prima facie breach of the person’s right to a fair trial if the decision 
to detain has not been made in accordance with the law, if the person has had no 
opportunity to challenge the detention, if there is no time limit given to the period 
of detention and if there is no appeal or review process.
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  The detention of someone who has not yet been confi rmed as infectious is prob-
lematic as the person may pose no risk at all to public health. Quarantine procedures 
with time limits accompanied by regular medical examination to confi rm infectious-
ness would be more appropriate.
2  A person suffering from MDRTB can potentially create a public health risk. 
Where that person complies with a treatment regime and with advice on limiting 
contact with others, there is no need to compulsorily detain. Hence it might be argu-
able that it is justifi ed to take into account that person’s capacity to comply. However 
such an assessment involves passing judgement not on the person’s physical state of 
health but on psychological and social factors. Public health offi cials may not have the 
necessary skills to undertake these judgments. It would be easy for judgments to be 
made on social or racial stereotyping rather than on the attributes of the individual. 
The history of the exercise of public health powers tells us that attribution of 
irresponsible disease behaviours to particular sections of society has been 
common, especially in the context of disease epidemics and pandemics. Any such 
judgment must be made on concrete evidence of the person’s previous health 
behaviours and not on an assumption of non-compliance based on ethnicity or 
socioeconomic status.
3  This would amount to a breach of the right to a fair trial. Wherever a person is detained, 
be it for the commission of a criminal offence or for the protection of public health, the 
infringement of the person’s right to liberty cannot be indefi nite or infi nite. The person 
is entitled to know the proposed length of detention, and that time period must be 
justifi able on public health grounds and must be challengeable. The detention time need 
not be specifi ed in terms of days or months, but could be predicated on an event, such 
as a confi rmation that the person is no longer infectious.
4  Western legal systems support the notion of autonomy. Every person with capacity 
to make decisions about their health is entitled to choose whether to consent to, or 
refuse, medical treatment. The fact that someone is suffering from an infectious dis-
ease does not lesson that person’s capacity to make an autonomous decision. 
However, refusal of treatment, and failure to treat, could result in the detention of a 
person indefi nitely if the person continues to be infectious. Such a person would 
need to be monitored regularly to determine continued infectiousness, as continua-
tion of detention must be justifi ed on grounds that the risk of that person to the 
health of the public outweighs the infringement of their rights.
5  Singh’s comments were made in the context of a different culture, with different 
beliefs, ethics and legal culture. Western health ethics, and laws, assume the autonomy 
of the individual and prioritize autonomy over other values such as communitarian-
ism, family or tribal loyalty, etc. The African Charter on Human and People’s Rights 
for example, unlike the European Convention on Human Rights, makes clear that 
individuals owe duties to their family and their community, and that rights do not 
prevail over the public good. Asian values based on Confucianism and Buddhist 
beliefs would take a similar approach. Hence the answer to this question will depend 
on the culture and ethics beliefs of the population of the state.
6  The level of disease risk in each state will be relevant to the assessment of risk. 
The compulsory detention or treatment of a person with disease must be justifi ed 
by an assessment that on balance, the risk created by the infectious person 
outweighs the infringement of rights. So seriousness of the level of disease, access 
to medical resources, closeness of living quarters etc. will all input into the 
assessment of risk that person creates to the health of others. This is not to say 
there are differing levels of human rights. The rights remain the same, and the 
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principles for assessment of protection of those rights remain the same, but the facts 
on which those principles are to be determined differ. It is also the case that the 
culture and ethics of the society will be relevant in determination of the balance 
between public good and private right. Imposition of western interpretations of 
human rights on African and Asian states has been rejected as ‘cultural imperialism’. 
African and Asian values, so long as they are debated and supported by the public, 
should be taken into account in the determination of how rights are to be protected 
and enforced.
ARMED CONFLICT
Armed confl ict and public health
The deaths, injuries and illness attributable to armed confl ict are major contributors 
to the global burden of disease (Murray et al. 2002). The discipline of public health 
plays a crucial role in mitigating the impact of armed confl ict on health. In this section 
you will learn how confl ict can have an impact on the health of civilian populations, and 
then examine key epidemiological approaches that should be used by humanitarian 
organizations to help understand the scale of health needs and the impact of the 
humanitarian response.
Learning objectives
By the end of this section you should be able to:
• describe how armed confl ict can infl uence health
• explain the direct and indirect effects of armed confl ict on health
• discuss the key epidemiological approaches used to measure the health status of 
confl ict-affected populations
Key terms
Armed confl ict There are various defi nitions of armed confl ict, but a commonly 
used defi nition of major armed confl ict is one that has over a 1,000 battle-related 
deaths in one year.
Household surveys Collection of information from a representative sample of 
households on health events.
Mortality rate The number of deaths occurring in a given population at risk dur-
ing a specifi ed time period. In confl ict-affected settings, this is usually expressed as 
deaths per 10,000 persons per day.
Surveillance The systematic collection and analysis of information over time to 
regularly monitor changes in health.
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Background on armed confl ict
There was an overall rise in the number of armed confl icts globally since the 1950s, 
with the majority being protracted civil confl icts between a national government and 
irregular armed groups, rather than international confl icts between countries. Civil 
wars are extremely complex in nature and often have many causes. These include: 
grievances over exclusion from economic resources, the scope to gain from potential 
spoils of war; entrenched economic and social inequalities, extreme poverty, economic 
stagnation and high unemployment; environmental degradation and scarcity of 
resources; political exclusion, weak governance, high militarization and a history of 
confl ict; and ethnicity and religion (often exploited by political leaders) (Stewart 2002).
Although international law provides legal protection for civilians in times of war 
(Box 9.1), many confl icts are characterized by the deliberate targeting of civilians who 
may be killed, raped, maimed and abducted (Bruderlein and Leaning 1999). Civilian 
populations may also be forcibly displaced from their homes by violence and insecurity. 
These forcibly displaced populations currently include around 27 million internally dis-
placed persons (IDPs) who have fl ed their homes but remain within the national bor-
ders of their own country and around 15 million refugees who have fl ed across an 
international border into a neighbouring country.
Refugees and IDPs have most commonly lived in camp settings but a relative major-
ity now reside in urban areas, a phenomenon that presents new challenges for the way 
in which health services are provided (Spiegel et al. 2010). Another sizeable proportion 
lives in rural areas. There are also many people in confl ict zones who, though not dis-
placed, have low access to essential health services, food and other basic needs due to 
surrounding insecurity.
Box 9.1  International law in confl ict-affected settings
There are a number of international treaties that seek specifi cally to protect civil-
ians and the humanitarian organizations providing relief services in times of war. 
International Humanitarian Law (notably the 1949 Geneva Conventions and their 
two 1977 Additional Protocols) includes the obligation for all parties to collect and 
care for the sick and the wounded, as well as the obligation to respect and protect 
hospitals, ambulances, and medical personnel, and to provide protection against rape 
and indecent assault. However, many instruments within International Humanitarian 
Law are primarily intended to cover international wars and their application and 
enforcement in civil wars is limited. This increases the challenge of providing health 
care in civil wars.
Refugee Law (The 1951 Refugee Convention and related 1967 Protocol) addresses 
the specifi c rights of refugees. The Convention requires participating countries 
to provide refugees protection and social support, including for their health. It also 
created the post of United Nations High Commissioner for Refugees to manage 
protection and support services for refugees. However, Refugee Law does not cover 
IDPs. Although IDPs are guaranteed certain basic rights under the Geneva 
Conventions, ensuring these rights is often the responsibility of those national gov-
ernments that were responsible for their displacement in the fi rst place. As a result, 
protection and support provided for IDPs can be severely lacking, including access 
to health care.
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The infl uence of armed confl ict on health
The ways in which armed confl icts infl uence health are specifi c to the individual con-
texts. Hence, it is necessary to take account of the underlying pre-confl ict conditions, 
the characteristics of the confl ict, and the impact of the confl ict itself (Figure 9.1). The 
underlying pre-confl ict risk factors include poverty and socioeconomic vulnerability 
(‘distal’ factors) which reduce the ability to withstand the impact of the confl ict. The 
underlying epidemiological conditions are also critical, with younger populations living 
in areas with a high burden of communicable disease (mainly sub-Saharan Africa and 
Asia) generally at higher risk. Weaker health systems are also less able to withstand 
confl ict than stronger systems, further reducing the availability of health services dur-
ing the confl ict.
Confl icts where there is a high intensity of violence towards civilians inevitably have 
a profound impact on health. Civilians may be attacked directly, forcibly displaced from 
Figure 9.1  Ways in which confl ict can infl uence health
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their homes, and suffer from destruction of health facilities. Similarly, longer durations 
of confl ict increase the impact on population health. Civil confl icts are frequently 
characterized by little adherence to human rights principles and International 
Humanitarian Law by combatants (see Box 9.1), leading to targeting of civilians and 
humanitarian organizations. Entrapped populations may be particularly vulnerable to 
such violence and loss of access to health services. Forced displacement can also have 
extremely detrimental consequences for health, particularly for IDPs living in very 
overcrowded camp conditions (for example, the camps in northern Uganda, Darfur 
and Somalia in the 2000s), and refugees who move into areas where support services 
are not yet available (for example, about ten per cent of the 500,000 to 800,000 
Rwandan Hutu refugees who fl ed into Goma, Zaire in 1994 died within one month – 
mainly due to cholera). However, it should be noted that long-established and well-
organized refugee camps are generally characterized by good health outcomes with 
mortality rates usually well below those of even the surrounding host community.
Armed confl ict infl uences the risk factors for ill health in a number of ways. It can 
delay or prevent access to health services due to the insecurity involved in travelling 
to health facilities, destruction of health facilities, health workers being forced to fl ee, 
and vital medicine and supply chains being disrupted. Importantly, it frequently disrupts 
vaccination and disease control programmes resulting in outbreaks of infectious dis-
ease. Already poor nutritional status may worsen due to inability to grow or purchase 
food because of insecurity, displacement and impoverishment. Rising malnutrition 
increases vulnerability to infection, especially among children and elderly people. 
Confl ict and displacement commonly result in worsening living conditions as people 
are forced to fl ee into makeshift settlements which are often characterized by limited 
access to clean water, adequate sanitation and thus poor hygiene (increasing the risk of 
diarrhoeal diseases, such as cholera and typhoid), inadequate shelter (increasing the 
risk of diseases such as pneumonia and other respiratory infections) and overcrowd-
ing (increasing the risk of diseases such as measles, acute respiratory infections and 
tuberculosis).
Direct and indirect health effects
Civil confl icts are often extremely protracted (lasting on average for ten years) and 
so have extremely long-term effects on health, both during the war and long after it. 
These health effects can be divided into direct effects sustained in the fi ghting, such 
as deaths and injuries, and indirect effects resulting from an increase in the risk of 
infectious and non-infectious disease and poor nutrition. As noted above, the majority 
of indirect deaths occur among children and elderly people, and arise from preventable 
communicable diseases such as acute respiratory infections, diarrhoeal diseases, 
tuberculosis and malaria (with malnutrition, measles and HIV as common underlying 
conditions).
The ratio between direct and indirect effects depends on the timing and context of 
the confl ict. It is common for the direct effects to predominate in the early stages of 
confl ict as people die from the violence (particularly young men), but indirect effects 
take over as living conditions, health services and nutritional status deteriorate.
The burden of indirect effects is substantially higher in confl ict-affected populations 
living in tropical and very poor settings because of underlying endemic communicable 
diseases and limited access to health services, food, and income. It is estimated 
that between 70 and 98 per cent of war-related mortality in nine major confl icts in 
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sub-Saharan Africa since 1945 was due to the indirect effects of preventable and treat-
able diseases (Human Security Centre 2005).
Armed confl ict also affects reproductive health because of the lack of access to 
health services, impoverishment and exposure to violence. Extremely high rates of 
sexual violence by combatants against civilians have been reported during wartime 
but also increasingly by civilians against other civilians in long-term chronically 
insecure situations such as those in the eastern part of the Democratic Republic of 
Congo. High rates of mental illness have also been recorded among confl ict-affected 
populations as a result of exposure to violent and traumatic events, poor living condi-
tions, insecurity, impoverishment, disrupted social norms, and the loss of livelihoods 
(Miller and Rasmussen 2010). There is also growing awareness of the impact of confl ict 
on chronic diseases such as diabetes and heart disease among displaced persons in 
middle-income settings, such as IDPs in Georgia (Spiegel et al. 2010). The damage 
caused to health by civil confl icts extends well beyond the period of active warfare, 
with women and children the most affected by their prolonged effects (Human Security 
Centre 2005).
The role of public health in confl ict-affected settings
There is broad consensus on the types of public health interventions required in 
confl ict-affected situations. This consensus is formalized in the Sphere Guidelines 
and Handbook which provide the main standards for humanitarian interventions 
(see Box 9.2).
Box 9.2  Sphere Guidelines – key health interventions
• Initial assessment
• Suffi cient and safe water, adequate sanitation facilities
• Suffi cient food and nutrition supplements
• Mass vaccination
• Disease surveillance, outbreak preparedness and control
• Primary health care and referral hospital services for severe cases
• Shelter and site planning
• Reproductive health services
• Mental health and psycho-social care
Public health disciplines are essential in guiding decision-making to prioritize optimal 
activities within the agreed interventions outlined in Sphere and to ensure they are: (i) 
addressing the main health problems (e.g. high risk diseases); (ii) providing adequate 
coverage to meet health needs; and (iii) effective (and cost-effective) in addressing health 
needs. However, a fundamental challenge in quantifying the health impacts of confl ict is 
that health information systems, particularly registration systems that record deaths and 
the causes of death, often cease to function in confl ict-affected areas (indeed in many 
low-income confl ict-prone countries they may not have been functioning before the 
confl ict). In the absence of functioning standard health information systems, the meth-
ods commonly used to obtain health information to guide decision-making are rapid 
assessments, surveillance and surveys. This data collection is commonly carried by 
humanitarian organizations.
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Rapid assessments
Rapid assessments provide a quick means of informing decision-making at the onset 
of a crisis. Types of information include: the characteristics of the confl ict, such as 
general levels of insecurity and targeting of civilians; demographic and socioeconomic 
characteristics of the affected populations; health profi les of the affected area, in terms 
of endemic and epidemic-prone diseases; availability and functionality of health services; 
and living conditions and availability of food and clean water. Potential sources of infor-
mation include:
• existing situational reports;
• media reports;
• databases and maps of global distribution of specifi c diseases;
• records of past disease outbreaks in the affected area or similar areas;
• past reports from health information system.
However, rapid assessments do have limitations due to the quantity and quality of 
available data and the trade-off between rapidity and quality of data collection. 
These reports are unlikely to provide accurate data on mortality rates, prevalence or 
incidence of diseases and acute malnutrition, or the impact of health interventions.
Surveillance systems
Surveillance systems provide the most important means of monitoring population 
health effectively in crisis-affected settings, providing trends in mortality, prevalence of 
acute malnutrition and enabling detection of epidemics (i.e. monitoring the burden 
of disease and the impact of interventions). Surveillance systems in confl ict-affected 
settings may include: (i) health-facility based surveillance of epidemic-prone diseases, 
either from an exhaustive list of facilities or a few sentinel sites; (ii) demographic 
surveillance to monitor trends in mortality rates, by collecting information on births 
and deaths from all households by means of home visitors; and (iii) more specialized 
systems consisting of repeat surveys to monitor HIV at risk behaviours and prevalence, 
acute food insecurity and malnutrition prevalence. Surveillance systems should be 
established in the affected area as soon as is possible.
Household surveys
Cross-sectional household surveys are commonly used to collect data at a single 
point in time on crude and under-5 mortality rates (see Box 9.3) and on prevalence 
of acute malnutrition, in places where functioning surveillance systems do not exist. 
Follow-up surveys can then be used to identify any changes in these outcomes 
(so indicating the possible impact of interventions). A range of other health outcomes 
are also measured by household surveys (albeit far less frequently) such as maternal 
mortality, mental health conditions such as post-traumatic stress disorder and 
depression, HIV-related behaviour, and experience of sexual and gender-based vio-
lence. Surveys are also used to provide essential information on the coverage of inter-
ventions (e.g. vaccinations, therapeutic feeding, water and sanitation, and access to 
health care).
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Box 9.3  Mortality data in confl ict-affected settings
The primary goal of any comprehensive humanitarian programme should be to 
reduce loss of life. Crude and under-5 mortality rates are therefore crucial indica-
tors to understand the nature and severity of the crisis, and the Sphere Guidelines 
use mortality rates to categorize whether there is an emergency or not (stating that 
a doubling of pre-confl ict baseline mortality can be considered an emergency situa-
tion). Mortality rates are also essential in understanding the impact of humanitarian 
relief (i.e. in reducing the loss of life).
The difference between the observed mortality rate during the confl ict and the 
mortality rate in the pre-confl ict baseline period represents the excess mortality 
rate caused by the confl ict. The excess mortality rate can be applied to the popula-
tion and period it refers to in order to estimate the absolute number of excess 
deaths caused by the confl ict. For example, it was estimated that there were 5.4 
million war-related excess deaths (the vast majority from disease) in the Democratic 
Republic of Congo between 2000 and 2007. This represents a catastrophic combina-
tion of elevated mortality rates for a very large population over a long period of 
time (Coghlan et al. 2007).
Very approximate causes of mortality (e.g. disease, violence, pregnancy-related) 
can be collected by home visitors and lay data collectors. More specifi c and accurate 
causes of death can be recorded by using verbal autopsy questionnaires adminis-
tered by trained clinical personnel.
Challenges for public health
Despite general agreement on the key interventions required in humanitarian settings, 
there has often been a failure to deliver them (United Nations 2005). Recent measures 
seek to strengthen coordination and accountability within the global humanitarian 
community, including the development of sectoral guidelines for the health sector 
(IASC 2009); a major obstacle to effective delivery of appropriate services remains the 
lack of detailed knowledge of health needs in particular contexts. This is largely due to 
a failure of humanitarian organizations (and country governments where they are still 
functioning) to conduct surveillance and surveys. As a result, essential information on 
health needs and the impact of interventions is missing. This also impedes global com-
parisons on the extent of humanitarian need, so risking inequitable targeting of aid and 
other resources. Instead there is a tendency for humanitarian organizations to collect 
process information (e.g. the number of health services provided) rather than informa-
tion on outputs (e.g. coverage of interventions) or impact (e.g. changes in mortality 
rates). Even when surveillance and surveys are conducted, many are of a poor standard, 
often with low sensitivity for deaths that may have occurred. Household surveys very 
frequently feature inadequate sampling and insuffi cient sample sizes as well as multiple 
other biases, which can result in erroneous fi ndings and imprecise results, and lead to 
potentially ineffective humanitarian responses (Prudhon and Spiegel 2007; Working 
Group for Mortality Estimation in Emergencies 2007).
There are several reasons for the failure to collect adequate surveillance and 
survey data. Insecurity and logistical challenges inhibit data collection, particularly for 
surveillance systems among dispersed populations. Donor agencies tend to favour 
process rather than impact indicators and are reluctant to pay for resource-intensive 
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surveillance systems. Donors may be reluctant to fund collection of data that do not 
relate specifi cally to the activities they are undertaking. Importantly, there is limited 
capacity within many humanitarian organizations to conduct fi eld epidemiology to a suf-
fi ciently rigorous standard, sometimes coupled with a failure to recognize its value. These 
reasons need to be addressed so that the quantity and quality of data collected among 
confl ict-affected populations can be improved (Roberts and Hofmann 2004).
Activity 9.2
Figure 9.2 shows crude mortality rates (CMR) (per 10,000 persons per day) over a 
12-month period in a confl ict-affected population in sub-Saharan Africa. What factors 
do you think may explain the changes in the crude mortality rate?
Figure 9.2  Mortality rates over a 12-month period in a confl ict-affected population in sub-Saharan Africa
Feedback
Months 1 to 2 show a stable baseline rate fairly typical of the region (i.e. pre-confl ict). 
Months 3 to 4 show a substantial increase in CMR, well above the baseline rate 
(therefore an emergency according to Sphere Guidelines). This increase could be 
attributable mainly to the direct effects of an outbreak of armed confl ict (i.e. violence-
related deaths). The slight fall in month 5 could be as violence reduces. The continuation 
of the high CMR in months 5 to 8 could be attributable to the indirect effects of the 
confl ict such as increases in communicable diseases. The decrease in CMR in months 9 
to 12 could be due to improved security and humanitarian interventions resulting in 
better access to health services, food, shelter, clean water and sanitation. However, the 
CMR in month 12 remains above double the baseline rate and so it should still be 
considered an emergency situation and further interventions are required to continue 
reducing the CMR.
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Conclusion
In this section you have learnt about the ways in which armed confl ict can infl uence 
health and key public health priorities in confl ict-affected settings. You also learnt about 
the essential need for good epidemiological research in confl ict-affected settings.
GENETICS
The emerging relevance of public health genetics
By its nature, our genome has infl uenced the health of the human population since the 
origins of mankind. Predisposition to, or causation of disease spanning all aetiologies 
and organ systems is, to varying degrees, mediated by our genes. Whilst the most 
potent effects of genetic variation on human health (Mendelian diseases such as 
Huntington’s chorea or cystic fi brosis) were among the fi rst to be recognized, these 
are rare and a comprehensive examination of the more subtle genetic infl uences on 
common diseases has taken decades to develop. In recent years, knowledge of the 
human genome sequence has permitted a much wider and more detailed investigation 
of genetic determinants of disease.
Here we illustrate some ways in which genetic information has infl uenced popula-
tion health, and the wide range of opportunities for intervention to improve public 
health emerging from this rapidly developing area.
Learning objectives
By the end of this section you should be able to:
• understand key concepts in genetic epidemiology and how the unique features of the 
genome make it a valuable tool for investigating and infl uencing population health
• appreciate the importance of the human genome sequence to recent develop-
ments in genetic epidemiology and how it has facilitated research that has implica-
tions for population health
• understand the role of contemporary genetic research in identifying novel oppor-
tunities for improving population health and the potential for incorporating 
genetics into mainstream clinical care, therapeutics and prevention
• appreciate differences in the implications of genetics and genomics for the health 
of individuals and of populations
Key terms
Complex disease Conditions occurring frequently in the population, often with 
multi-factorial aetiologies (thus there is often an interplay between genes and environ-
ment). Examples are coronary heart disease and type II diabetes.
Genome The sum of all of an individual’s genetic information.
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Genome-wide association study (GWAS) Large epidemiological study comparing 
frequencies of SNPs across the entire genome between groups with, and without a par-
ticular phenotype (e.g. type II diabetes or a circulating biomarker, e.g. blood cholesterol).
Genotype The composition of an individual’s DNA at a particular point (locus) or 
area of the genome.
Linkage study Epidemiological study designed to identify sequences of DNA 
shared by individuals with a common phenotype, often a disease.
Locus A defi ned point in the genome, which may be a single base (e.g. a SNP), a whole 
gene, a cluster of genes or another, larger area that may or may not contain any genes.
Mendelian disease Diseases where a single mutation gives rise to a major, deleteri-
ous phenotype and is inherited in a Mendelian pattern through a family. Examples 
include Duchenne muscular dystrophy and some familial hyperlipidaemias.
Mutation Usually refers to a larger change in genotype with more substantial phe-
notypic consequences, such as a large insertion or deletion of nucleotide bases.
Phenotype The physical, biological manifestation of a gene, which may be simple 
(e.g. the concentration of a protein in the bloodstream) or complex (a personality or 
behaviour). Phenotype is also determined by environment.
Polymorphism A small change in an individual’s DNA sequence, usually limited to 
a few nucleotide bases, that may or may not infl uence the individual’s phenotype: for 
example, a single nucleotide polymorphism (SNP).
Single nucleotide polymorphism (SNP) A change from one nucleotide base to 
another at a particular location in the genome; SNPs accounts for the majority of 
genetic variation between individuals.
The pre-genome era
A key question in investigating the genetic architecture of disease is the degree to 
which risk of developing that disease (e.g. coronary heart disease, CHD) or variation 
in a risk factor associated with it (e.g. blood pressure, BP) is determined by genetic 
variation. Much of the research has used studies of identical (monozygotic) twins, 
who have the same genes but, especially where separated at birth, may have been 
exposed to different environments. The resulting heritability estimates vary consider-
ably between traits (e.g. 50 per cent for CHD, 80 per cent for height). Scientists have 
gone on to try to identify the individual genes underlying this genetic component of 
disease, with results being harnessed for interventions in population health, including 
(i) improved disease prediction; (ii) elucidating novel pathogenic pathways and uncover-
ing potential therapeutic and preventive targets; (iii) so-called ‘personalized’ medicine.
Before today’s technological capacity to genotype many thousands of genetic variants 
rapidly, genetic studies to investigate disease causation in humans were typically per-
formed using either linkage or candidate gene studies. Linkage analysis involves the 
investigation of an individual with a disease (e.g. familial hypercholesterolaemia) and 
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their close relatives, both affected and unaffected by the disease, in order to identify 
DNA sequences shared by the affected individuals. Candidate gene studies investigate 
variation at a single genetic locus, typically in a case-control study design. However, this 
approach requires an a priori hypothesis that the genetic variant is implicated in disease, 
yielding several potential sources of error. First, genetic variation underpinning disease 
that is not already known – and which may yield important information about previously 
unknown aspects of a disease – will not be detected. Second, candidate gene studies are 
prone to bias in study design, which has led to many years of inconsistent results.
Identifying the majority of genetic determinants of disease required an approach 
for identifying variants without an a priori hypothesis. This hypothesis-free approach 
(the genome-wide association study, GWAS) performs multiple tests of association 
between several hundred thousand genotyped single nucleotide polymorphisms 
(SNPs) and disease status and employs statistical techniques to minimize false positive 
associations (Type 1 errors) likely to arise from such a large number of tests.
Sequencing the genome
Completed in 2003, the sequencing of the entire human genome was a task of unprec-
edented size. Composed of over 3 billion base-pairs and containing around 25,000 
genes, the genome took a large, international collaboration 13 years to construct and 
laid out for the fi rst time the full blueprint of the human body, providing opportunities 
for insights into its function in health and disease. Since 2003, technological advances 
have been a major catalyst in exploiting and applying the genome sequence data. 
Identifi cation of SNPs across the genome and their cataloguing by the International 
HapMap Project have permitted a large-scale, quantitative approach to assessing 
genetic associations with many diseases and other traits, notably in the form of 
genome-wide association studies (GWAS).
Although many new loci have emerged from the growth of GWAS (catalogued at 
www.genome.gov/gwastudies), the resulting biomedical revolution predicted by some 
has not fully materialized. Expectations of the potential of GWAS to provide ground-
breaking insights into the pathophysiology of the world’s great diseases have been dis-
proportionately high and several features limit their direct translation into clinical use. 
SNPs identifi ed by GWAS studies appear to account for only a small amount of the 
heritability of traits estimated from monozygotic twin studies and the inference has 
been drawn that we have yet to discover all of the genetic determinants of many dis-
eases. However, given the infl uence of natural selection on the genome, whereby the 
most harmful genetic variants are least likely to persist across generations (unless their 
effects only manifest after reproductive age, for example, Huntington’s disease), genetic 
variants causing large differences in disease susceptibility are unlikely to be found com-
monly in the population. The most likely variants to be found by a method such as 
GWAS are common ones with modest effects. Although this may be seen as a limita-
tion of GWAS, SNPs of modest effect can have a substantial effect on population health.
The post-genome era
Much research using the genome sequence has examined genetic determinants, identi-
fi ed by GWAS studies, of pathophysiology, therapeutics and prevention in a range of 
disorders. Identifi cation of variants associated with a complex disease such as type II 
diabetes has propelled investigation of the role of these genes in disease aetiology; the 
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translational potential of this investigation for population health is substantial. Mendelian 
randomization (MR) is a tool that exploits genetic information (often from GWAS) 
to this end, permitting causal inference that minimizes confounding and obviates 
reverse causation – two major limitations of traditional epidemiology (Figure 9.3). For 
example, using Mendelian randomization, the causal role of alcohol consumption in 
oesophageal cancer has been confi rmed. Previous non-genetic observational studies 
were limited by confounding – since alcohol consumption is strongly correlated with 
smoking, and smoking is strongly associated with oesophageal cancer, it had been 
diffi cult to disentangle the role of alcohol using only non-genetic observational data. 
Furthermore, a randomized controlled trial of alcohol exposure would be diffi cult 
and perhaps unethical to implement. Using the ALDH2 gene as an instrumental variable 
of alcohol exposure, because different variants of the gene infl uence an individual’s 
tolerance, and thus consumption of alcohol, researchers were able to demonstrate 
that gene variants associated with higher alcohol intake were also associated with 
greater risk of oesophageal cancer, providing evidence of the causal role of alcohol that 
was free from confounding by tobacco.
Figure 9.3  The use of Mendelian randomization in epidemiology
Activity 9.3
List three examples of potentially causal exposures in common disease that could be 
investigated through Mendelian randomization. List the benefi ts of MR over (i) obser-
vational (non-genetic) research and (ii) randomized controlled trials, which are both 
conventional sources of evidence for causality in such conditions.
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Feedback
Large numbers of putative risk factors are frequently reported by the lay press for con-
ditions such as cancers. Examples are easily found in national daily newspapers. You 
might have included the following examples, although there are many other possibilities:
(i) coffee and cancer
(ii) artifi cial sweeteners and heart disease
(iii) aluminium and Alzheimer’s disease
Advantages of MR over
(i) observational studies
• MR minimizes confounding.
• MR eliminates reverse confounding.
• The genetic ‘exposure’ in MR studies is very robustly characterized, whilst 
exposures in observational epidemiology may be more diffi cult to measure. 
For example, a gene associated with intolerance to a particular food may 
infl uence intake over a lifetime, providing a better measure than a food diary 
kept for a week several decades earlier.
(ii) Randomized controlled trial
• MR studies cost less and take less time than RCTs.
• MR studies can easily be performed on a very large scale (i.e. not limited by 
the number of individuals recruited to a RCT).
• Using a genetic ‘exposure’ may prevent exposure to a potential drug or therapy.
• Large amounts of available data in MR studies allow investigation of a wide 
range of phenotypic associations with the genetic variant in question.
• Genetic studies avoid ethical diffi culties of exposing individuals to potentially 
harmful exposures.
• Genetic variation refl ects lifetime exposure to the phenotype altered by the 
genetic variant. In contrast, most randomized trials have durations of weeks 
or months, and, very rarely, years. Hence, through MR studies, differences in 
disease risk arising from lifetime exposure to phenotypes can be measured.
Predicting risk of common disease
Predicting which individuals in a population will develop a serious disease has long been 
a goal in individual and population health care, so as to be able to intervene to prevent 
cases from developing (primary prevention). Coronary heart disease (CHD) is a good 
candidate for prediction, since it is a common condition with a long preclinical phase, and 
well-established evidence for the causal roles of high blood pressure and elevated levels 
of circulating blood lipids. Moreover, effective behavioural and pharmacological interven-
tions allow these risk factors to be modifi ed early to reduce the risk of future disease.
At present, physicians calculate an individual’s absolute risk of developing CHD 
within 10 years using models like the Framingham Risk Equation (Score) that take into 
account familiar risk factors such as smoking, cholesterol levels and age. The predicted 
risk from these models is used to decide whether, and how, to reduce a person’s risk 
of developing CHD, based on agreed thresholds. However, these non-genetic risk 
equations are not perfect predictors of disease risk. It is well recognized that genes 
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infl uence risk of disease, thus it may be possible to incorporate genetic information 
into risk scores. Furthermore, genotype is becoming increasingly cheap to measure 
and, in comparison to non-genetic risk factors (e.g. smoking), it is fi xed at conception. 
However, whilst genotype appears a panacea for prediction, its clinical translation has 
been hampered for several reasons. First, genetic variation accounts for only a small 
proportion of the variance of the risk of diseases like CHD, and the effects of com-
monly measured variants on disease risk are modest. Second, since the architecture of 
genetic variation differs between ethnic groups, a variant predicting disease in one 
group may be unusable in another. Furthermore, and most importantly, Geoffrey Rose’s 
‘Prevention Paradox’ (Rose et al. 2008) extends to genetics – because risk alleles 
are inherited independently (under Mendel’s law), most individuals with a common 
disease such as CHD are exposed to average, and not markedly unusual, risk alleles 
(Figure 9.4). Hence, setting a threshold for high-risk genotype (as one might in conven-
tional risk prediction) to distinguish people likely to develop CHD from those that are 
not, is unlikely to be very helpful. Indeed, epidemiological studies that have incorpo-
rated genetic information into established risk equations have reported only very small 
or no improvement in predicting disease events. It is possible that emerging technolo-
gies will uncover rarer alleles that have greater effect estimates though their rarity 
Figure 9.4  The prevention paradox analogy
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may render population screening to detect them ineffi cient. Nonetheless, as more loci 
are associated with disease development, genetic information may gain utility when 
incorporated in disease prediction.
Activity 9.4
List the characteristics of an ideal predictive test for a chronic disease, such as CHD, 
that has a major impact on population health. Briefl y, browse the literature available 
online to fi nd any currently available or proposed tests that fi t your criteria. What are 
the benefi ts and limitations of genetics for predicting diseases like CHD?
Feedback
Ideal features of a predictive test include the examples below. Many of these characteris-
tics also apply to conventional screening tests.
•  The test should be cost-effective to perform and must be able to be used on a large, 
population scale.
• The marker measured by the test should not change markedly with time.
•  Measurement of the marker should not be operator-dependent (which can intro-
duce error).
•  The test should accurately designate individuals as high or low risk, or as cases or 
non-cases of the outcome in question (i.e. perfect discrimination – this is only rarely 
possible).
•  A treatment for the condition in question should be available that is acceptable to 
patients, effi cacious (i.e. prevents recurrence or occurence of disease), has no major 
adverse effects and is cost effective in the prevailing health care system.
•  Treatment of those identifi ed as ‘at risk’ reduces risk of disease to nil (NB this is 
unlikely at present for most genetic disorders).
• The test should be acceptable to the individual.
• The disease has a major impact on public health.
• The natural clinical course of the disease is well understood.
Pharmacogenomics
One of the most widely anticipated applications of genetic information is to predict 
response to treatment or prevention interventions – an example of ‘personalized 
medicine’. A person’s genotype may infl uence how they respond to therapeutic sub-
stances. You can identify whether your genes code for the fast of slow variants of the 
enzyme that breaks down drugs by acetylation in the liver by whether coffee at night 
keeps you awake (slow) or not (fast). Such a response could be either an intended 
effect (for example, the degree to which a statin reduces cholesterol) or an undesired, 
harmful effect. Pharmacogenetics is growing rapidly, with a surge in research articles 
published since the 1990s. However, only a few pharmacogenetic tests – predominantly 
in cancer medicine – are currently used, owing principally to an inadequate evidence 
base. Here we briefl y contrast two pharmacogenetic tests that have shown different 
utility for clinical use: abacavir and HLA-B*5701 and warfarin and CYP2C9/VKORC1.
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Abacavir – a drug used in the treatment of HIV – is effective in controlling HIV 
infection but can cause a life-threatening hypersensitivity reaction in some individuals. 
A variant has been identifi ed in the HLA-B*5701 gene that predisposes individuals to 
this adverse reaction and consequently abacavir is not prescribed to people with the 
high-risk genotype in order to avoid this serious side effect – a pharmacogenetic 
success story.
Warfarin, a widely prescribed anticoagulant (blood-thinning agent) used in treating 
cardiovascular disease, presents a contrasting scenario. Warfarin is only effective in 
preventing harmful blood clots at a narrow range of doses, which is close to the range 
of drug levels that cause harm. Polymorphisms in the CYP2C9 and VKORC1 genes have 
been associated with the therapeutic response to warfarin. However, the studies 
concerned mostly investigated surrogates for warfarin effi cacy rather than major clini-
cal events associated with it and the real utility of genotype in predicting warfarin 
treatment response is, therefore, still uncertain.
Activity 9.5
What would be the key benefi ts to population health of an effective pharmacogenetic 
test?
Feedback
Key benefi ts include:
• substantial reductions in the incidence of adverse drug reactions;
•  optimization of the intended effects of therapy; together, these will increase 
the therapeutic and preventive benefi ts of drug therapy, minimize the burden of 
disease caused by drugs, thus reducing costs to health care systems, maximizing 
cost-effi cacy and optimizing the benefi t of the intervention in the population;
•  increased drug concordance (i.e. with knowledge that the drug prescription is 
‘personalized’ to an individual, they may be more likely to take it as prescribed).
A substantial, and familiar, limitation of pharmacogenetics is that common genetic vari-
ants are unlikely to explain much of the variability in drug response in a population. 
Many non-genetic factors such as drug dosing, concomitant drug use and the degree to 
which patients take their medications as prescribed by their doctor (concordance) are 
likely to play a role. If we are to use genetic information to predict therapeutic response 
more accurately, it will probably need to be incorporated with non-genetic informa-
tion. As with risk prediction, an ability to predict response to a preventive or therapeu-
tic intervention has important consequences for the effi cacy of prevention and 
treatment strategies in the population.
Population genomics vs personal genomics
It is important to distinguish between the applications of genetic research for individu-
als and for populations. Common genetic variants tend to have small effects, which 
are, consequently, only detectable in very large samples; indeed, it is not uncommon 
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for collaborative genetic studies to include hundreds of thousands of participants. 
The identifi cation of a genetic variant associated with increased risk of myocardial inf-
arction in such a study is likely to be of greater value in infl uencing the health of a 
whole population than of an individual since it may suggest a novel risk factor or an 
opportunity for pharmacological or behavioural prevention. Nonetheless, the vogue 
for personal genetic testing for such variants is growing. Marketed principally by com-
mercial companies at prices that are falling rapidly, personalized genetic tests for a 
range of SNPs identifi ed by GWAS studies for their association with many common, 
and several rarer conditions are offered to consumers. At present the clinical value of 
these tests to either the individual or the population has not been demonstrated, 
although future research may increase their utility in risk assessment and drug pre-
scription. However, there is ongoing debate about the need to ‘protect’ the public from 
direct-to-consumer advertising of genetic tests, as their utility is not known.
The entry of genomics into public consciousness may, it has been suggested, have 
important implications for public health and health behaviours. As more associations 
between genes and common risk factors emerge, such as obesity, physical inactivity and 
smoking, and those fi ndings become increasingly newsworthy, it is possible that obese 
individuals or smokers may begin to attribute risk factors increasingly to their geno-
type, believing them to be outside their control and therefore not amenable to modi-
fi cation for risk reduction. Important questions are therefore raised about appropriate 
marketing and publicity surrounding genetic information, particularly in an increasingly 
health-literate and information-driven society.
Genetics offers many powerful tools for investigating how common diseases develop 
and how they might be prevented or treated. While the fi eld of population genomics is 
moving rapidly, it has yet to have a material impact on the population’s health. The 
potential it holds, however, in risk assessment, risk factor identifi cation and better 
targeting of prevention and treatment is great and is likely to eventually bear fruit.
Activity 9.6
Use the Internet to identify two direct-to-consumer genetic testing services. Consider 
the ethical implications of this type of marketing and service provision. List the 
advantages and disadvantages of direct-to-consumer genetic testing in general, paying 
particular attention to:
• benefi ts to individual health;
• benefi ts to public health;
• cost-effectiveness;
• viability for use in mainstream health care.
Feedback
Several companies, including 23andMe (https://www.23andme.com) and deCODEme 
provide such services, offering information on risk of around 95 diseases, and providing 
genetic information to predict drug response; the cost of testing your genome is 
currently approximately US$400. Table 9.1 illustrates the main advantages and disad-
vantages of direct-to-consumar testing.
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Table 9.1  Advantages and disadvantages of direct-to-consumer genetic testing
Advantages Disadvantages
Individual health •  Knowledge of one’s genome can aid 
motivation in adopting risk-reducing 
behaviours
•  Genomic futility (rather than motivate 
lifestyle modifi cation, individuals with 
‘bad’ genes may decide such action is 
futile)
•  Most SNPs have small effect and 
therefore individually will not yield 
much information
Public health •  Can be incorporated into a 
prediction model
•  Individuals who pay for genetic 
testing may subsequently participate 
in research studies
•  Widening the spectrum of inequality (at 
least initially, it is likely that only the 
well-off will pay for their genome 
sequence)
Cost-effectiveness •  Cost is relatively low, and decreasing •  Is the genetic information of suffi cient 
clinical value to yield value-for-money?
Mainstream health 
care
•  Rapid, low cost testing for a large 
number of genetic markers may, in 
the future, yield more information 
more quickly than conventional 
laboratory tests.
•  Patients may hold their genetic data 
indefi nitely, compared to time-limited 
conventional test results.
•  Superiority over conventional testing 
and prediction methods may take some 
time to be proven.
•  Health care workers will need 
extensive training in the application and 
interpretation of many genetic testing 
techniques.
Summary
This chapter introduced you to three of the newest areas of public health research and 
practice, which are doubtless going to become more prominent in the years to come. 
You are encouraged to keep up to date with the emerging evidence from each of these 
areas, regardless of where your public health career takes you, as a reminder of the 
ever-expanding role of public health and its importance to the future of mankind and 
of civilization.
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